Course Director:
Guillermo Umpierrez, MD
Professor of Medicine
Chief of Diabetes and Endocrinology
at Grady Memorial Hospital
Division of Endocrinology and Metabolism
Emory University School of Medicine
Director of Diabetes Education and Training Academy
Atlanta, GA
Program Overview
This activity will explore strategies to improve glycemic and metabolic outcomes in patients with type 2 diabetes mellitus (T2D). A review of clinical trial data will enable clinicians to personalize the selection of therapies for patients and examine the role of emerging dual GIP and GLP-1 receptor agonists in the management of type 2 diabetes.
Who Should Attend:
This educational activity is intended for endocrinologists, primary care physicians, and other clinicians involved in the treatment of patients with type 2 diabetes.
Learning Objectives:
Upon completion of this activity, participants should be better able to:
- Select therapies for the improvement of glycemic and extra-glycemic outcomes in patients with type 2 diabetes.
- Determine the rationale for targeting GIP and GLP-1 receptors in the treatment of type 2 diabetes and its metabolic comorbidities.
- Identify patients in their own practice who may potentially benefit from treatments targeting GIP and GLP-1 receptors in the future based on knowledge of recent clinical data
Certification: Upon successfully completing the activity, physicians may download a Certificate of Participation
Course Duration: The estimated time for completion of the course is 1.5 hours.
Available: April (TBA), 2025 - April (TBA), 2026
There are no fees required to participate in this activity.
This educational activity is supported by Lilly